Moderna CFO James Mock Vests RSUs with Routine Tax Withholding
Moderna, Inc.
Subscribe to track MRNA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
### Insider Filing: Moderna, Inc. (NASDAQ: MRNA)
**Filing Date:** October 7, 2026
**Insider:** James M. Mock (Chief Financial Officer)
**Significance:** Low (Routine RSU Vest & Tax Withholding)
- **Acquired:** 1,454 shares via RSU vesting ($0.00)
- **Withheld for Taxes:** 704 shares @ $190.01 (~$133.77K)
- **Net Shares Retained:** +750 shares
- **Post-Transaction Holdings:** 60,125 shares
Comprehensive Analysis
Transaction Summary
On October 5, 2026, Moderna Chief Financial Officer James M. Mock executed routine equity-award transactions:
- RSU Conversion (Code M): 1,454 Restricted Stock Units vested and converted into common shares on a 1-for-1 basis at no cost.
- Tax Withholding (Code F): 704 shares of common stock were surrendered to the issuer at a price of $190.01 per share ($133,767.04 total value) to satisfy tax liabilities associated with the vesting event.
- Following these transactions, Mock directly owns 60,125 shares of Moderna common stock.
Market & Trading Significance
This filing carries Low informational significance. The transactions represent standard equity compensation vesting and statutory tax withholding rather than discretionary open-market buying or selling. It signals no change in executive sentiment toward company prospects.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.